← back to search

Gavin Giovannoni

Queen Mary University of London · GB
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Peripheral Neuropathies and Disorders, and Immunotherapy and Immune Responses.
h-index
31
citations
5,172
works
87
NIH funding
primary concept
email

Recent publications

Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
Multiple Sclerosis Journal 2022cited by 46position: middledoi
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
The Lancet 2012cited by 1,194position: middledoi
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence
Multiple Sclerosis Journal 2012cited by 129position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Douglas L. Arnold · Montreal Neurological Institute and Hospital2 papers (2012–2022) · 1 papers (2012–2012)Daniela Piani-Meier · Merck KGaA, Darmstadt (Germany)1 papers (2022–2022)Shannon Ritter · Virginia Tech1 papers (2022–2022)Nicolas Rouyrre · Novartis (Switzerland)1 papers (2022–2022)Bruce Cree · California State University, Bakersfield1 papers (2022–2022)Patrick Vermersch · UNSW Sydney1 papers (2022–2022)Edward Fox · Pennsylvania State University1 papers (2012–2012)Goeril Karlsson · Hospital for Sick Children1 papers (2022–2022) · 1 papers (2012–2012)Robert J. Fox · Cleveland Clinic1 papers (2022–2022)Ralph H. B. Benedict · Palacký University Olomouc1 papers (2022–2022)E. Waubant · Multiple Sclerosis Center of Atlanta1 papers (2012–2012)Krzysztof Selmaj · Medical University of Lodz1 papers (2012–2012)Michael Panzara · New York University1 papers (2012–2012)Alasdair Coles · University of Cambridge1 papers (2012–2012)Ludwig Kappos · Department of Biomedicine Basel1 papers (2022–2022)Ralf Gold · Lead Discovery Center (Germany)1 papers (2022–2022)Hans‐Peter Hartung · The University of Sydney1 papers (2012–2012)Howard L. Weiner · Harvard University1 papers (2012–2012)